We found that decreasing the expression level of GNG5 in glioma cells could significantly affect the expression of VCAM1, ICAM1, CDH2, and SDC2, which are key molecules of cell adhesion molecules (Fig. 5b, c). Here, VCAM1 is linked to central nervous system cancer.